⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

BBIO

BridgeBio Pharma, Inc.

Healthcare · Biotechnology

76.08USD

+1.3200 (+1.77%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 76.08
P/E—
Dvd Ind Yld—
P/B—
P/S20.9
Curr EV/T12M EBITDA-37.1
Mkt Cap (USD)14.9B
Curr EV (USD)17.5B
2)

Per Share Data

EPS T12M-3.59
DPS0.01
Bk Val Per Sh-12.88
Rev/Sh3.64
Cash/Sh3.68
Curr Shares Out195.5M
FCF/Sh-2.22
3)

Cash Flow Analysis

P/CF-34.2
Curr P/FCF-34.2
CF/NI0.6
Dvd P/O-0.1%
Cash Gen/Cash Reqd-215.9
Csh Dvd Cov-435.7
CFO/Sales-60.9%
Eff Interest Rate3.7%
4)

Growth Potential

Dil EPS 1Y Gr-31.3%
Cap 1Y Gr92.3%
BPS 1Y Gr-38.1%
R&D To Sales70.9%
Retention Rate100.1%
Rev 1Y Gr126.3%
FCF 1Y Gr14.3%
Assets 1Y Gr1.8%
5)

Profitability

EBITDA-0.5B
EBIT-0.5B
Operating Margin-69.8%
Pretax Margin-100.8%
Net Margin-98.5%
ROA-61.1%
ROE32.6%
ROC—
Asset Turnover0.62
6)

Structure

Current Ratio1.23
Quick Ratio1.09
Debt/Assets218.2%
Debt/Com Eq-105.6%
Net Debt/EBITDA-4.02
Tot Debt/Capital1880.0%
Gross Margin94.4%
EBIT/Int Exp-10.0

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.